These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22287703)

  • 1. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
    Vanholder R
    Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations on clinico-chemical correlations in uraemic polyneuritis.
    Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 5. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 6. Determinants of uraemic toxin removal.
    Clark WR; Gao D
    Nephrol Dial Transplant; 2002; 17 Suppl 3():30-4. PubMed ID: 11912297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A purification method by uncoated charcoal.
    Cerulli N; Politi L; D'Angelo AR; Scandurra R
    Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemofiltration-induced serum modifications in the pattern of larger molecules.
    David S; Barani R; Buzio C; Arisi L; Quaretti P
    Adv Exp Med Biol; 1987; 223():281-6. PubMed ID: 3447447
    [No Abstract]   [Full Text] [Related]  

  • 9. Removal of high-molecular-weight toxins.
    Hörl WH
    Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous measurement of DTPA-clearance in extracorporeal detoxification circuits.
    Falkenhagen D; Ahrenholz P; Roy T; Esther G; Kiencke H; Klinkmann H
    Artif Organs; 1981; 4 Suppl():166-8. PubMed ID: 7295085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic toxins.
    Ringoir S; Schoots A; Vanholder R
    Kidney Int Suppl; 1988 Mar; 24():S4-9. PubMed ID: 3283412
    [No Abstract]   [Full Text] [Related]  

  • 12. [Removal of middle molecule peptides from the blood during hemodialysis].
    Bakaev VV; Khomenko VF
    Lab Delo; 1989; (1):64. PubMed ID: 2468036
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of toxic activity of blood in uremia].
    Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
    Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialysis therapy: 'think differently'.
    Perrone B
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v1-2. PubMed ID: 17586840
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 17. Paired filtration-dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uraemic patients.
    Ghezzi PM; Zucchelli P; Ringoir S; Nigrelli S; Santoro A; Gervasio R; Sanz Moreno C; Vanholder R; Botella J
    Adv Exp Med Biol; 1987; 223():267-75. PubMed ID: 3328955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of waste metabolites in uremia by microencapsulated reactants.
    Sparks RE; Salemme RM; Meier PM; Litt MH; Lindan O
    Trans Am Soc Artif Intern Organs; 1969; 15():353-9. PubMed ID: 5791409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.